Item 16. FORM 10-K SUMMARY

Not applicable.


			Dow Inc. and Subsidiaries
			The Dow Chemical Company and Subsidiaries
			Valuation and Qualifying Accounts			Schedule II


(In millions) For the years ended Dec 31,	2020		2019		2018
Accounts Receivable - Allowance for Doubtful Receivables
Balance at beginning of year	$	45	$	42	$	59
Additions charged to expenses 1	22		24		10
Additions charged to other accounts 2	—		—		4
Deductions from reserves 3	(16)		(21)		(31)
Balance at end of year	$	51	$	45	$	42
Inventory - Obsolescence Reserve
Balance at beginning of year	$	35	$	23	$	18
Additions charged to expenses	2		19		7
Deductions from reserves 4	(14)		(7)		(2)
Balance at end of year	$	23	$	35	$	23
Reserves for Other Investments and Noncurrent Receivables
Balance at beginning of year	$	2,215	$	460	$	430
Additions charged to expenses 1	7		1,758		44
Deductions from reserves 5	(129)		(3)		(14)
Balance at end of year	$	2,093	$	2,215	$	460
Deferred Tax Assets - Valuation Allowance
Balance at beginning of year	$	1,262	$	1,225	$	1,255
Additions charged to expenses	313		140		152
Deductions from reserves	(273)		(103)		(182)
Balance at end of year	$	1,302	$	1,262	$	1,225

1.In 2019, additions charged to expenses for "Accounts Receivable - Allowance for Doubtful Receivables" included $2 million and additions charged to expenses for "Reserves for Other Investments and Noncurrent Receivables" included $1,753 million related to the Company's investment in Sadara Chemical Company ("Sadara"). See Note 12 to the Consolidated Financial Statements for additional information.

2.Additions to allowance for doubtful receivables charged to other accounts were classified as "Accounts and notes receivable - Other" in the consolidated balance sheets. These reserves relate to the Company's sale of trade accounts receivable. Anticipated credit losses in the portfolio of receivables sold were used to fair value the Company's interests held in trade accounts receivable conduits. See Notes 14 and 23 to the Consolidated Financial Statements for additional information.

3.Deductions included write-offs, recoveries, currency translation adjustments and other miscellaneous items.

4.Deductions included disposals and currency translation adjustments.

5.In 2020, deductions from reserves for "Reserves for Other Investments and Noncurrent Receivables" included $77 million related to the Company's investment in Sadara. See Note 12 to the Consolidated Financial Statements for additional information.


						Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries
						Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on February 5, 2021.


DOW INC.
THE DOW CHEMICAL COMPANY

/s/ RONALD C. EDMONDS
Ronald C. Edmonds, Controller and Vice President of Controllers and Tax (Authorized Signatory and Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below on February 5, 2021 by the following persons on behalf of the registrant and in the capacities indicated.



/s/ SAMUEL R. ALLEN						/s/ RONALD C. EDMONDS
Samuel R. Allen, Director, Dow Inc.						Ronald C. Edmonds, Controller and Vice President of Controllers and Tax, Dow Inc. and TDCC (Authorized Signatory and Principal Accounting Officer)

/s/ AJAY BANGA						/s/ JEFF M. FETTIG
Ajay Banga, Director, Dow Inc.						Jeff M. Fettig, Lead Director, Dow Inc.

/s/ GAURDIE BANISTER JR.						/s/ JIM FITTERLING
Gaurdie Banister Jr., Director, Dow Inc.						Jim Fitterling, Director, Chairman and Chief Executive Officer, Dow Inc. and TDCC (Principal Executive Officer)

/s/ JACQUELINE K. BARTON						/s/ JACQUELINE C. HINMAN
Jacqueline K. Barton, Director, Dow Inc.						Jacqueline C. Hinman, Director, Dow Inc.

/s/ JAMES A. BELL						/s/ HOWARD UNGERLEIDER
James A. Bell, Director, Dow Inc.						Howard Ungerleider, President and Chief Financial Officer, Dow Inc. and TDCC; Director, TDCC (Principal Financial Officer)

/s/ WESLEY G. BUSH						/s/ JILL S. WYANT
Wesley G. Bush, Director, Dow Inc.						Jill S. Wyant, Director, Dow Inc.

/s/ RICHARD K. DAVIS						/s/ DANIEL W. YOHANNES
Richard K. Davis, Director, Dow Inc.						Daniel W. Yohannes, Director, Dow Inc.


Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries
Trademark Listing

The following trademarks or service marks of The Dow Chemical Company and certain affiliated companies of Dow appear in this report: ACOUSTICRYL, ACRYSOL, AFFINITY, AMPLIFY, AQUASET, AVANSE, CARBOWAX, DOW, DOWANOL, DOWSIL, DOWTHERM, ECOFAST, ELITE, ENGAGE, EVOQUE, FORMASHIELD, IMAGIN3D, MAINCOTE, MOBILITYSCIENCE, NEOSEED, NORDEL, PRIMAL, RHOBARR, RHOPLEX, SENTRY, SILASTIC, SUNSPHERES, SYL-OFF, TAMOL, TERGITOL, TRITON, UCAR, UCON, VERSENE, WALOCEL

The following registered trademark of Disability:IN appears in this report: Disability Equality Index®

The following registered trademark of Incapital Holdings appears in this report: InterNotes®

The following registered service mark of American Chemistry Council in the United States appears in this report:

Responsible Care®

The following registered trademark of Great Place to Work® Institute, Inc. appears in this report: Great Place to Work®

The following registered trademark of The National Safety Council appears in this report: Green Cross for Safety®

® ™ Trademark of The Dow Chemical Company ("TDCC") or an affiliated company, except as otherwise specified.

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES